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Bacterial  chromosomes  may  contain  up  to  20%  phage  DNA that  encodes  diverse  proteins  ranging  from
those  for photosynthesis  to those  for autoimmunity;  hence,  phages  contribute  greatly  to  the  metabolic
potential  of  pathogens.  Active  prophages  carrying  genes  encoding  virulence  factors  and  antibiotic  resis-
tance  can  be excised  from  the  host  chromosome  to form  active  phages  and  are  transmissible  among
different  bacterial  hosts  upon  SOS  responses.  Cryptic  prophages  are  artifacts  of mutagenesis  in which
lysogenic  phage  are  captured  in  the  bacterial  chromosome:  they  may  excise  but  they  do  not  form  active
phage  particles  or lyse  their  captors.  Hence,  cryptic  prophages  are  relatively  permanent  reservoirs  ofntibiotic tolerance
orizontal gene transfer
oxin–antitoxin system
genes,  many  of which  beneﬁt  pathogens,  in  ways  we  are  just  beginning  to discern.  Here  we  explore  the
role  of  active  prophage-  and  cryptic  prophage-derived  proteins  in terms  of (i)  virulence,  (ii) antibiotic
resistance,  and  (iii)  antibiotic  tolerance;  antibiotic  tolerance  occurs  as  a  result  of the  non-heritable  phe-
notype  of dormancy  which  is a result  of  activation  of toxins  of  toxin/antitoxin  loci  that  are  frequently
encoded  in  cryptic  prophages.  Therefore,  cryptic  prophages  are promising  targets  for  drug  development.
© 2016  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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. IntroductionBacteriophages and bacteria are the most abundant life forms
n Earth. They also interact frequently, and each phage infec-
ion has the potential to introduce new genetic material into the
∗ Corresponding author at: Key Laboratory of Tropical Marine Bio-resources and
cology, South China Sea Institute of Oceanology, Chinese Academy of Sciences,
uangzhou 510301, PR China.
∗∗ Corresponding author at: Department of Chemical Engineering, Pennsylvania
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ttp://dx.doi.org/10.1016/j.drup.2016.06.001
368-7646/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article 
/).bacterial host, thereby driving the evolution of bacteria. The intro-
duction of novel genes by phages into the bacterial host can confer
beneﬁcial phenotypes that enable the exploitation of competitive
environments (Canchaya et al., 2003; Lawrence and Ochman, 1998;
Penadés et al., 2015). For example, marine bacteriophage encode
photosynthesis genes which may  provide relief from intense sun-
light in oceans for the phage and host (Mann et al., 2003), as well as
encode adaptive bacterial immune systems to provide immunity
from competing phage known as clustered regularly interspaced
short palindromic repeats (CRISPR)/CRISPR-associated (Cas) sys-
tems (Bellas et al., 2015).
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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tig. 1. Different types of phages and prophages. Genes in cryptic prophages are abb
oxin–antitoxin systems.
Among the beneﬁcial genes, phages provide DNA for virulence,
esistance, and tolerance to antibiotics as three major factors for
athogens during infection. Resistance involves genetic mutations
hat allow for growth in the presence of antibiotics whereas toler-
nce involves metabolic dormancy from the activation of toxins
f toxin/antitoxin (TA) systems that allows pathogens to sleep
hrough a course of antibiotic treatment (Wood, 2016).
Treating pathogenic bacteria that evade antibiotics has become
 global issue. This review will focus on the virulence, resistance,
nd tolerance genes carried by prophages, the antibiotics or other
hemicals that can trigger the spread of these genes by prophage
xcision/integration, and also some preventative strategies to treat
athogens by targeting prophages. We  also emphasize ways to
void the adverse effects of triggering virulence dissemination by
rophages.
. Prophages are reservoirs of virulence genes
Bacteriophages provide one of the most efﬁcient vehicles for
oving DNA sequences (their own and the host’s DNA by mis-
ake), via transduction, between bacterial cells. Horizontal transfer
f genetic information by phages is much more prevalent than pre-
iously thought, and the environment plays a crucial role in the
hage-mediated transfer of virulence genes (Penadés et al., 2015).
he relatively high numbers of phage (1030 phage and approximate
atio of 10 phage to each bacterium) leads to frequent lytic and
ysogenic phage infections (1025 infections/s) (Chibani-Chennouﬁ
t al., 2004). Unlike lytic phages, temperate phages are integrated
nto the bacterial genome and maintain a long-term lysogenic rela-
ionship with their hosts (Fig. 1). Lysogeny has a unique role withined as int:  integrase, xis: excisionase, RM: restriction–modiﬁcation systems, and TA:
the bacterium-phage arms race in that it favors the development
of a symbiotic relationship by providing an ecological window for
the evolution of mutually-beneﬁcial functions (Feiner et al., 2015).
Hence, these frequent phage infections provide ample opportunity
to affect virulence.
There are major differences both between and within different
bacterial species in their ability to cause infection. Opportunis-
tic and pathogenic bacterial species include Escherichia coli, Vibrio
cholerae, Pseudomonas aeruginosa,  Listeria spp., Salmonella enterica,
Enterococcus faecalis, Streptococcus spp., and Staphylococcus spp. A
major driving force in the emergence and evolution of pathogenic
isolates is the horizontal transfer and acquisition of virulence
factors. Several mobile genetic elements (insertion sequences,
plasmids, bacteriophages, and pathogenicity islands) have been
implicated in the horizontal transfer of virulence genes; one of the
most signiﬁcant groups is the bacteriophages (reviewed in Hastings
et al. (2004)).
Lysogenic conversion by prophages encoding toxins and other
virulence determinants is the most ostensible contribution to bac-
terial pathogenesis (Brussow et al., 2004). Many diseases are caused
by toxins that are encoded by phages such as diphtheria, cholera,
dysentery, botulism, food poisoning, scalded skin syndrome, necro-
tizing pneumonia or scarlet fever (Hacker and Kaper, 2000). Among
these, exotoxin production such as scarlatinal toxin, cholera toxin
and Shiga toxin is the among the best documented virulence fac-
tors (Wagner and Waldor, 2002). Bacteriophages can also alter host
physiology to increase virulence at different stages of infection,
including bacterial adhesion, colonization, invasion, resistance to
host immune defenses, and transmissibility among human host (as
reviewed by Wagner and Waldor (2002)).
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The contribution of phages to pathogenicity was ﬁrst discov-
red in streptococci in 1927 when it was shown that nontoxic
treptococci acquired the ability to produce scarlatinal toxin
hrough the phages released by the toxic streptococci (Frobisher
nd Brown, 1927). In the 1950s, toxin-encoding bacteriophages
f Corynebacterium diphtheria further linked phages to bacte-
ial pathogenicity (Barksdale and Arden, 1974; Freeman, 1951;
roman, 1953).
The cholera toxin of V. cholerae illustrates well a case of how
ultiple phages contribute to bacterial pathogenicity (Brüssow and
endrix, 2002; Davis et al., 2000; Karaolis et al., 1998, 1999; Waldor
nd Mekalanos, 1996). Shiga toxin (Stx) is present in Shigella dysen-
eriae type 1 and shiga toxin producing E. coli (STEC). Two major
lasses of Stx are found in STEC, Stx1 and Stx2. The stx genes
n E. coli strains are the central contributors to the virulence of
nterohemorrhagic E. coli (EHEC), and EHEC infection can cause
loody diarrhea and can lead to hemolytic anemia, thrombocy-
openia, renal failure, and even to death (Kaper et al., 2004). Stx
n E. coli O157:H7 is encoded as a late gene product by temperate
acteriophage integrated into the chromosome. Phage late genes,
ncluding stx,  are silent in the lysogenic state, and Shiga toxin (Stx)
roduction depends on the activation of the Stx prophage. Stress
ignals, including some induced by antibiotics, trigger the phage
o enter the lytic cycle, and phage replication and Stx production
ccur concurrently (Kaper et al., 2004).
Prophage also plays a role in the virulence of P. aeruginosa.  P.
eruginosa is an important opportunistic pathogen with a broad
ost range (plants, invertebrates, and vertebrates) (Palleroni, 1984),
nd P. aeruginosa is the most common cause of chronic lung infec-
ions in cystic ﬁbrosis (CF) patients (Lyczak et al., 2002). The Pf4
rophage is essential for several stages of the P. aeruginosa bioﬁlm
ife cycle, and it signiﬁcantly contributes to its virulence in vivo
Mai-Prochnow et al., 2004; Rice et al., 2009).
S. enterica serovar Typhimurium harbors two functional
rophages, Gifsy-1 and Gifsy-2 that contain virulence genes
Figueroa-Bossi and Bossi, 1999). Prophage Gifsy-2 carries the sodC
ene for a periplasmic [Cu, Zn]-superoxide dismutase involved with
he defense against killing by macrophages (Farrant et al., 1997).
he removal of both prophages leads to a signiﬁcant attenuation of
irulence, and the removal of prophage Gifsy-2 signiﬁcantly reduces
he ability of S. enterica serovar Typhimurium to establish a systemic
nfection in mice (Figueroa-Bossi and Bossi, 1999).
In Staphylococcus aureus,  expression of the phage encoded sea,
eg2, sek2 and sak toxins is greatly increased following prophage
nduction (Sumby and Waldor, 2003). In S. aureus,  tst,  the gene
hat encodes toxic shock syndrome toxin, is carried by a 15 kb
ong pathogenicity island (Hochhut and Waldor, 1999). Prophage
nd prophage-like elements are also the major sources of variation
etween the genomes from Streptococcus pyogenes strains involved
n two distinct pathologies, wound infections and rheumatic fever.
he prophages encode several secreted proteins involved in the
uman–bacterium interaction, including the scarlet fever toxin.
The mammalian intestine is home to a dense community
f bacteria and its associated bacteriophage, which inﬂuence
irulence. The Gram-positive bacterium E. faecalis is a natural
nhabitant of the mammalian gastrointestinal tract and is com-
only found in soil, sewage, water, and food, frequently through
ecal contamination (Matos et al., 2013). E. faecalis is an oppor-
unistic pathogen that is a major cause of urinary tract infections,
acteremia and infective endocarditis, and E. faecalis V583 har-
ors a composite phage derived from two distinct chromosomally
ncoded prophage elements. One prophage encodes the struc-
ural genes necessary for phage particle production and the other
rophage is required for phage infection of susceptible host bacte-
ia. E. faecalis V583 uses phage particles to establish and maintain
ominance of its intestinal niche in the presence of closely-relatedce Updates 27 (2016) 30–38
competing strains. Recent studies of the human fecal virome show
that temperate rather than lytic phages are long-term contribu-
tors to the microbial host phenotype through provision of adaptive
genes (Reyes et al., 2010).
3. Prophages are reservoirs of antibiotic resistance genes
Many microorganisms produce secondary metabolites with
antimicrobial activities and release them into their natural habi-
tats. These antibiotic-producing microorganisms are resistant to
the antibiotics they produce, but for the non-resistant bacteria,
they need to develop resistance mechanisms to ensure survival
in these environments (Muniesa et al., 2013). The presence of
antibiotics in the environment may  exert long-term selective pres-
sure for the emergence and horizontal transmission of resistance
mechanisms in the non-producing microorganisms. In recent
years, the explosive spread of antibiotic-resistance determinants
among pathogenic, commensal, and environmental bacteria has
reached a global dimension. Prophages not only encode toxin
genes for human pathogens but also carry genes that enhance the
ﬁtness of the bacterial cell in ecological niches (Hendrix, 2003). For
example, prophages contain genes that provide protection from
attack by other phages, such as restriction-modiﬁcation systems
(Vasu and Nagaraja, 2013) and CRISPR/Cas systems (Deveau
et al., 2010). Growing evidence shows that phages also carry
or transfer genes that participate in other cellular process such
as inactivating antibiotics (Muniesa et al., 2013). Erythromycin
resistance methylases (Erm) confer resistance to three classes of
clinically-important antibiotics (the macrolides, the lincosamides,
and the streptogramins B), and are widespread in Staphylococcus
and other bacterial species (Seppälä et al., 1998). For example,
in Staphylococcus xylosus isolated from bovine mastitis milk, a
novel macrolide–lincosamide–streptogramin B resistance gene
is located on a 53-kb prophage that is site-speciﬁcally integrated
into the S. xylosus chromosome (Wipf et al., 2014). In Staphylo-
coccus ﬂeurettii, this gene is located in a genomic island which
is site-speciﬁcally integrated into the housekeeping gene guaA,
and exhibits the ability to circularize (Wipf et al., 2015). Transfer
of erythromycin resistance via prophages of clinically isolated S.
pyogenes was  suggested to be responsible for the emergence of
streptococci with multiple resistances in the clinical environment
(Hyder and Streifeld, 1978). P1 bacteriophages lysogenize bacteria
as independent plasmid-like elements, and a recent report shows
that P1-like bacteriophage carrying SHV-2 extended-spectrum
-lactamase is present in clinical strains of E. coli (Billard-Pomares
et al., 2014). Acquired resistance to -lactam antibiotics is con-
ferred principally by -lactamases and penicillin-binding proteins
(Livermore and Woodford, 2006). Two -lactamase genes and one
gene encoding a penicillin-binding protein have been detected
in the bacteriophage DNA fraction of sewage, river water, and
fecal waste from farmed animals, suggesting that bacteriophages
can be environmental vectors for the horizontal transfer of
antibiotic resistance genes (Colomer-Lluch and Muniesa, 2011).
Quinolone antibiotic resistance genes (qnrA and qnrS) have also
been found in phage DNA isolated from urban wastewater and
animal wastewater, suggesting that spreading genetic informa-
tion via bacteriophages has gained importance in the resistance
dissemination in environments (Colomer-Lluch et al., 2014).
Prophages may  also become trapped in the host genome due
to mutation (Canchaya et al., 2003); these inactive prophage
elements are referred to as cryptic prophages (Fig. 1), and they also
play a role in antibiotic resistance and tolerance. For example, the
E. coli K-12 genome has gained 1600 kb of novel DNA (18%) since
its divergence from Salmonella sp. 100 million years ago (Lawrence
and Ochman, 1998), and contains one active Lambda prophage
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Table  1
Summary of genes that participate in antibiotic resistance or tolerance in the cryptic prophages of E. coli K-12.
Gene name Prophage Function Antibiotics tested References
ydaC rac Putative double-strand break
reduction protein
Erythromycin Soo et al. (2011)
ralR rac DNase, toxin of type I TA pair RalR/RalA Fosfomycin Guo et al. (2014)
kilR rac Toxin, FtsZ inhibitor Novobiocin, bicyclomycin, azlocillin Peter et al. (2004), Sabina et al. (2003)
relE Qin Toxin of TA pair RelE/RelB,
sequence-speciﬁc endoribonuclease
Cefotaxime, oﬂoxacin, tobramycin,
ciproﬂoxacin, ampicillin
Gotfredsen and Gerdes (1998), Keren
et al. (2004), Maisonneuve et al. (2011)
dicB Qin Control of cell division Azlocillin Wang et al. (2010)
hokD Qin Small toxic membrane polypeptide Kanamycin, novobiocin Kohanski et al. (2007), Peter et al.
(2004)
emrE DLP12 Multidrug resistance pump Methyl viologen, tetracycline,
ethidium; tetraphenylphosphonium
Morimyo et al. (1992),  Yerushalmi
et al. (1995)
ompT DLP12 Outer membrane protease Streptomycin, chlortetracycline Hui et al. (2010),  Li et al. (2008)
yfdO CPS-53 Uncharacterized protein Lidocaine, nalidixic acid Soo et al. (2011)
rnlA CP4-57 Toxin of RnlA/RnlB TA pair Gentamicin Koga et al. (2011)
yfjZ CP4-57 Antitoxin of putative TA pair YpjF-YfjZ Novobiocin Peter et al. (2004)
ypjF CP4-57 Toxin of putative TA pair YpjF-YfjZ Novobiocin Peter et al. (2004)
cbtA CP4-44 Antitoxin of TA pair CbtA/CbeA,
cytoskeleton bundling-enhancing
factor A
Norﬂoxacin, novobiocin Masuda et al. (2012), Sabina et al.
(2003)
cbeA CP4-44 Toxin of TA pair CbtA/CbeA,
cytoskeleton binding toxin
Norﬂoxacin, spectinomycin Masuda et al. (2012)
ykfI CP4-6 Toxin of putative TA pair YkfI-YafW Colicin E3 Walker et al. (2004)
Colici
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tyafW CP4-6 Antitoxin of putative TA pair YkfI-YafW 
yagE CP4-6 2-Keto-3-deoxy gluconate (KDG)
aldolase
nd nine cryptic prophages (Blattner et al., 1997). At least cryptic
rophage rac is a phage fossil that is present in other E. coli strains
aving been acquired over 4.5 million years ago, which appears
ore ancient than the Lambda prophage (Perna et al., 2001). These
ryptic prophage are not inactive DNA remnants generated in
he course of host evolution but are important for host ﬁtness
n terms of both antibiotic and stress resistance (Wang et al.,
010). For example, by deleting all the cryptic prophage genes
n E. coli (166 kb), it has been shown that that cryptic prophages
ontribute signiﬁcantly to resistance to sub-lethal concentrations
f quinolone and -lactam antibiotics and that the prophages are
eneﬁcial for withstanding osmotic, oxidative, and acid stresses
Wang et al., 2010).
Speciﬁcally, the nine cryptic prophages in E. coli K-12 con-
ain 165 putative genes, and 50 of them are related to antibiotic
esistance either by transcriptome studies or in whole genome
creening tests (Kohanski et al., 2007; Peter et al., 2004; Walker
t al., 2004). As shown in Table 1, 17 cryptic prophage genes affect
ntibiotic resistance by survival tests or metabolic activity assays
sing deletion strains or using plasmids to express these prophage
enes. In particular, the products of kilR in rac prophage and dicB
n Qin prophage are responsible for inhibiting cell division and
re important for resistance to nalidixic acid (a quinolone) and
zlocillin (a -lactam) (Wang et al., 2010). YdaC encoded by rac
as identiﬁed in the screen for antibiotic resistance using pooled
lasmids from the ASKA library that showed increased resistance to
rythromycin (Soo et al., 2011), and we have conﬁrmed this phen-
otype in surivial assays using two different constructs to express
daC (unpulished data). Rac-like prophage is transmissible to other
. coli strains (Asadulghani et al., 2009), thus enabling it to spread
hese resistance genes.
In Gram-negative bacteria, antimicrobial agents must traverse
oth the outer membrane and plasma membrane to gain entry
nto the cell. One of many effective cellular resistance strategies
nvolves the extrusion of the antimicrobial from the cell by trans-
orters, which may  be anchored in the inner membrane or reside in
he trans-membrane space and which are also encoded by cryptic
rophage. For example, the transporter ethidium multidrug resis-
ance protein E (EmrE) in E. coli is a proton-dependent secondary
ransporter from cryptic prophage DLP12 (Yerushalmi et al., 1995).n E3, kasugamycin Walker et al. (2004)
iocin, norﬂoxacin, ampicillin,
omycin
Bhaskar et al. (2011), Peter et al. (2004)
EmrE confers resistance to positively charged hydrophobic antibi-
otics such as tetracycline by actively expelling the drug (Viveiros
et al., 2005). Outer membrane protease OmpT from prophage DLP12
has been shown to increase resistance to streptomycin and chlorte-
tracycline (Li et al., 2008). The impact of OmpT on E. coli resistance
to urinary cationic peptides was  investigated by testing an ompT
knockout strain, and OmpT may  help the host persist longer in the
urinary tract by enabling it to resist the antimicrobial activity of
urinary cationic peptides (Hui et al., 2010).
In other species, many resistance genes are located on genomic
islands, and there are several common features shared by cryp-
tic prophage and genomic islands. Both of them harbor phage
integrase or excisionase that directly regulate the integration or
excision of these mobile elements. Another common feature is the
presence of two perfect or near-perfect repeats at the borders of
these mobile genetic elements, and they are used as site-speciﬁc
recombination events during excision. P4 or P4-like integrase genes
are normally adjacent to the tRNAs or tRNA modiﬁcation genes,
which serve as the phage attachments (Williams, 2002). Mobile
genetic elements that carry P4-like integrases are termed cryp-
tic prophages in E. coli (e.g. CP4-6, CP4-44, CP4-57) but often
are referred to as genomic islands or pathogenicity islands in
other species such as Salmonella and Shigella. For example, the
genomic island that carries resistance to ampicillin, chlorampheni-
col, streptomycin, sulfonamides, and tetracycline in S. enterica
Typhymurium phage type DT104 is ﬂanked by a near perfect 18-bp
repeat and inserted in the trmE gene encoding a tRNA modiﬁcation
enzyme (Cabedo et al., 1999). The resistance locus pathogenicity
island in Shigella spp. mediates resistance to streptomycin, ampi-
cillin, chloramphenicol, and tetracycline, and it can be excised
from the chromosome via site-speciﬁc recombination mediated
by the P4-like integrase (Turner et al., 2004). We have shown in
E. coli that excisionase AlpA in CP4-57 can lead to a complete
removal of CP4-57 prophage (Wang et al., 2009) and that exci-
sionase XisR in rac and a modiﬁed host protein H-NS can lead to
a complete removal of rac prophage (Hong et al., 2010; Liu et al.,
2015). Therefore, the global dissemination of multiple antibiotic
resistances harbored by mobile genetic islands in pathogenic bacte-
ria seems to be closely related to the site-speciﬁc recombination
events.
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. Prophages are reservoirs of antibiotic tolerance genes
In many cases, TA loci are closely linked to mobile genetic ele-
ents. For example, V. cholera has 13 TA pairs and all of them
re clustered in the megaintegron on ChrII, the smaller of its two
hromosomes (Budde et al., 2007; Gerdes et al., 2005). Also, type I,
ype II and type IV TA loci have been identiﬁed in the nine cryptic
rophages of E. coli (Table 1), indicating TAs are overrepresented in
. coli prophages (∼8%). The presence of these toxins is important
n that activation of all toxins to date leads to a dramatic increase
n persister cells (Chowdhury et al., 2016a; Wood, 2016). So these
ryptic prophages not only provide the means for antibiotic resis-
ance, but they also provide the means to make the cells dormant
nd more persistent.
The type I toxin/antitoxin pair RalR/RalA in E. coli rac cryptic
rophage increases resistance to broad-spectrum fosfomycin (Guo
t al., 2014), and the underlying mechanism remains to be deter-
ined. RelE toxin of Type II TA RelB/RelE in E. coli prophage Qin is
 sequence-speciﬁc endoribonulease which blocks translation by
leavage of mRNAs (Christensen et al., 2001; Neubauer et al., 2009).
ritically, RelE leads to high persister cell formation in the presence
f high concentraions of ciproﬂoxacin, ampicillin, and tobramycin
Keren et al., 2004; Koga et al., 2011). Also, the toxin of the type II
A system RnlA/RnlB of the E. coli cryptic prophage CP4-57 causes
nhibition of cell growth and rapid degradation of cellular mRNAs.
he toxin of ﬁrst recognized type IV TA pair, CbtA/CbeA in E. coli
ryptic prophage CP4-44, not only inhibits cell growth, but alters
ell shape by inhibiting the polymerization of cytoskeletal pro-
eins FtsZ and MreB via direct protein-protein interaction (Masuda
t al., 2012). Moreover, this TA pair has related to resistance to nor-
oxacin, novobiocin, and spectinomycin (Tan et al., 2011; Kohanski
t al., 2007; Masuda et al., 2012). The only other two homologous
A loci of CbtA/CbeA also reside in prophages, YkfI/YafW on E. coli
ryptic prophage CP4-6 and YpjF/YfjZ on E. coli cryptic prophage
P4-57 (Brown and Shaw, 2003). Interestingly, YkfI/YafW is related
o the resistance to bacteriocin colicin E3 (Walker et al., 2004), and
pjF/YfjZ is related to resistance to novobiocin (Peter et al., 2004).
ne of the most striking features of these P4-like cryptic prophages
n E. coli is that they are pervasively mosaic, with different seg-
ents seem to have distinct evolutionary histories (Brussow et al.,
004). The presence of three homologous TA loci in three P4-like
rophages (CP4-6, CP4-44, and CP4-57) suggests that horizontal
enetic exchange plays a dominant role in shaping these genome
rchitectures.
. Antibiotics trigger prophage excision
UV irradiation and mitomycin C (MMC)  are classical agents
hat can efﬁciently induce prophage excision in lysogenic bacteria
Otsuji et al., 1959). The SOS response is induced by UV radiation
r MMC,  and it can also be activated by antibiotics that inhibit DNA
eplication or inhibit DNA gyrase activities to produce single-strand
NA (ssDNA). During the course of repair of DNA damage, ssDNA
s produced (e.g., DNA crosslinks produced as a result of MMC).
rimethoprim (dihydrofolate reductase inhibitor) is an example of
n SOS-inducing antibiotic that inhibits DNA replication (Lewin and
myes, 1991). Fluoroquinolones, broad-spectrum antibiotics that
nhibit bacterial DNA gyrase and topoisomerase activity, also lead
o SOS responses by generating DNA double-strand breaks (Drlica
nd Zhao, 1997).
The genes coding for Shiga toxins are silent in lysogenic bacteria,
nd prophage induction is necessary for their efﬁcient expres-
ion and toxin production. Both toxins are usually encoded in
he genomes of bacteriophages (Stx phages), and they can lyso-
enize E. coli strains, thereby allowing a mechanism for toxince Updates 27 (2016) 30–38
dissemination via transfer of bacteriophages (Huang et al., 1987;
O’Brien et al., 1984). Shiga toxin-producing EHEC (O157 Sakai) pos-
sesses 18 prophages that encode numerous genes related to EHEC
virulence, including those for Shiga toxins and two other potent
cytotoxins (Hayashi et al., 2001). Nine out of the 18 prophages can
be excised to form a circle by MMC-mediated induction, and three
of them are transferable to the non-pathogenic commensal E. coli
strain K-12 and stably maintained in the new host (Asadulghani
et al., 2009). The induction of Shiga toxin-converting prophages in
EHEC also occurs in the presence of norﬂoxacin and under oxida-
tive stress (Łos´ et al., 2010). Hence, these cryptic prophages have a
high potential for disseminating virulence-related genes and other
genetic traits to other bacteria under stress conditions, and stress
activates pathogenicity.
Increased virulence caused by increased Stx production has
been related to stx prophage induction both in vitro (Mühldorfer
et al., 1996) and in vivo (Zhang et al., 2000). In particular,
clinically-used antibiotics known to trigger the SOS response,
including ciproﬂoxacin, have been shown to enhance Stx produc-
tion (Mühldorfer et al., 1996). The SOS response induced by MMC
or ﬂuoroquinolones causes enhanced intra-intestinal transfer of
Stx2 prophages in vivo (Zhang et al., 2000). Prophages of E. fae-
calis V583 excise from the bacterial chromosome in the presence
of a ﬂuoroquinolone, and are able to produce active phage progeny
(Matos et al., 2013). The S. typhimurium functional prophages, Gifsy-
1 and Gifsy-2, can be induced by exposing bacteria to hydrogen
peroxide (Figueroa-Bossi and Bossi, 1999). Recent studies have
demonstrated that oxidative stress conditions may occur during
colonization of the human intestine by enteric bacteria (Kumar
et al., 2007). Moreover, earlier studies on a clinical isolate of EHEC
suggested that hydrogen peroxide produced by human neutrophils,
may  increase the production of Stx2 (Wagner et al., 2001).
Carbadox is a quinoxaline-di-N-oxide, and exposure of
Salmonella sp. to carbadox induces prophages that can transfer
virulence and antibiotic resistance genes to susceptible bacterial
hosts (Stanton et al., 2008). Carbadox frequently induces general-
ized transducing phages in multidrug-resistant phage type DT104
and DT120 isolates, resulting in the transfer of chromosomal and
plasmid DNA that included antibiotic resistance genes (Brunelle,
2014). Metagenomics approaches were used to evaluate the effect
of two  antibiotics in feed (carbadox and ASP250 [chlortetracy-
cline, sulfamethazine, and penicillin]) on swine intestinal phage
metagenomes (viromes), and the abundance of phage integrase-
encoding genes was signiﬁcantly increased in the viromes of
medicated swine over that in the viromes of non-medicated
swine (Allen et al., 2011). Prophage-like VSH-1 was  detected in
Brachyspira hyodysenteriae cultures treated with mitomycin C,
carbadox, metronidazole, and hydrogen peroxide. Carbadox- and
metronidazole-induced VSH-1 particles transmitted tylosin and
chloramphenicol resistance determinants between B. hyodysente-
riae strains (Stanton et al., 2008).
As previously described for SOS induction by MMC,  ﬂuoro-
quinolone antibiotics, and trimethoprim (Goerke et al., 2006),
-lactams are also capable of triggering prophage induction in S.
aureus lysogens. -lactam-mediated phage induction also resulted
in replication and high-frequency transfer of the staphylococcal
pathogenicity islands, showing that such antibiotics may have the
unintended consequence of promoting the spread of bacterial vir-
ulence factors (Maiques et al., 2006). -Lactam antibiotics are
extracellular stimuli of the SOS response in S. aureus as well as in
E. coli and demonstrate another case for horizontal dissemination
of virulence factors.Integrating conjugative elements (ICE) can also carry antibiotic
resistance genes and recruit SOS responses to mobilize them-
selves from one bacterial genome to another by cell-to-cell contact
(Hastings et al., 2004). Therapeutic agents such as ciproﬂoxacin
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nd MMC  promote the spread of antibiotic resistance genes car-
ied on ICE in V. cholerae among a variety of Gram-negative species
ncluding E. coli (Beaber et al., 2004; Hochhut and Waldor, 1999).
. Drugs and phage
Since MMC  and other antibiotics trigger SOS responses that
ay  contribute the augmentation of toxin production by induc-
ng stx prophage induction, the treatment of infections using
ntibiotics resulting in DNA damage and phage induction may
ead to unexpected adverse consequences. Stimulation of gene
ransfer following bacterial exposure to ﬂuoroquinolones should
e considered an adverse effect, and clinical decisions regarding
ntibiotic selection for infectious disease therapy should include
his potential risk. Antibiotics that inhibit protein synthesis, such
s chloramphenicol, tetracycline and streptomycin, do not induce
OS responses, and neither do agents that act upon the outer mem-
rane (Hastings et al., 2004). The use of fosfomycin which is an
nhibitor of cell-wall synthesis did not cause the intraintestinal
ransfer of Stx2 prophage transfer in mice (Zhang et al., 2000),
nd effectively reduced the risks of hemolytic-uremic syndrome
Takeda, 1998). Thus, efforts should be made in developing new
ompounds with antimicrobial activities targeting more speciﬁc
ellular functions/components rather than DNA replication. For
xample, lassomycin is a newly identiﬁed antibiotic that exhibits
otent bactericidal activity against both growing and dormant
ycobacteria. It binds to a highly acidic region of the ClpC1 ATPase
omplex and markedly stimulates its ATPase activity without stim-
lating ClpP1P2-catalyzed protein breakdown, which is essential
or viability of mycobacteria (Gavrish et al., 2014). Another newly
dentiﬁed antibiotic, teixobactin, from uncultured bacteria, inhibits
acterial cell wall synthesis by binding to a highly conserved motif
f lipid II (precursor of peptidoglycan) and lipid III (precursor of cell
all teichoic acid) (Ling et al., 2015).
In contrast to active prophages that are triggered to excise by
he DNA repair (SOS) response, cryptic prophages usually stay as
table residents on the host chromosome under adverse growing
onditions including during the SOS response. For example, for the
ine prophages in E. coli K-12, e14 was the only inducible prophage
pon MMC  treatment (Wang et al., 2010). Among the eight cryp-
ic prophages that do not excise with MMC,  two  prophages were
nduced to excise during E. coli bioﬁlm formation, thus provid-
ng beneﬁts for the population by creating a subpopulation of
rophage-excised cells with different bioﬁlm-related phenotypes
Liu et al., 2015; Wang et al., 2009). Furthermore, Pf4 prophage exci-
ion has been linked to both cell death and lysis for P. aeruginosa
ells in bioﬁlms as ﬁlamentous-like prophage excision increases
iversity in dispersing cells as well as impacts bioﬁlm architec-
ure and virulence (Rice et al., 2009; Webb et al., 2003). It is
ell established that bioﬁlms provide increased tolerance toward
ntibiotic treatment (Costerton et al., 1995), thus prophages can
lso indirectly contribute to antibiotic tolerance by promoting
ioﬁlm formation.
Moreover, cryptic prophages carrying TA systems can be
ctivated during stress (Yamaguchi and Inouye, 2011). During
xidative stress and starvation, proteases such as Lon and ClpXP
egrade unstable antitoxins and release free toxins (Christensen
t al., 2004; Maisonneuve et al., 2013; Wang et al., 2011; Wang
nd Wood, 2011). It has been suggested that activating toxins by
eactivating antitoxins of TA systems would be beneﬁcial in terms
ghting pathogens (Chan et al., 2015); however, this approach
s short-sighted in that this approach will indubitably lead to an
ncrease in the numbers of pathogen persister cells (Shapiro, 2013)
ince proteins that reduce growth such as toxins increase persis-
ence (Chowdhury et al., 2016a). Perhaps the best approach toce Updates 27 (2016) 30–38 35
target pathogens that utilize TA systems like those encoded by
phages to form persister cells, is to utilize a combination of drugs
with one used to kill growing cells and another one to kill persister
cells. Examples of this approach of targeting both growing and dor-
mant cells include combining rifampicin with the acyldepsipeptide
ADEP4 (Conlon et al., 2013) and by combining cefoperazone and
doxycycline with daptomycin (Feng et al., 2015). Other possible
approaches include using either mitomycin C (Kwan et al., 2015)
(for infections where it does not lead to extracellular toxin produc-
tion like Shiga toxins) or cisplatin (Chowdhury et al., 2016b) to kill
simultaneously both actively growing pathogens as well as their
persister cells; both compounds kill active and persister cells by
crosslinking their DNA, both have been shown to be broadly effec-
tive against pathogens such as P. aeruginosa,  EHEC, S. aureus,  and
Borrelia burgdorferi (Chowdhury et al., 2016b; Kwan et al., 2015;
Sharma et al., 2015), and both are approved by the Food and Drug
Administration for human use.
As an interesting use of TA systems from cryptic prophage as
drugs, toxin RelE from cryptic prophage Qin causes apoptosis when
it is produced in a human osteosarcoma cell line (Yamamoto et al.,
2002). Unfortunately, although toxins of TA systems have many of
the same targets as antibiotics, they are active only intracellularly;
i.e., they are not effective when added extracellularly but must be
translocated to the cell interior. For example, the Hok toxin of the
Hok/Sok TA system is not active with Gram positive or Gram neg-
ative bacteria unless it is electroporated into the cell (Pecota et al.,
2003).
Also, other non-TA components of prophage have potential as
drugs. For example, recent progress has been made in HIV-1 ther-
apy by directed evolution of a site speciﬁc recombinase that can
recognize a 34-bp sequence ﬂanking the majority of the integrated
provirus HIV-1; this evolved recombinase can efﬁciently and pre-
cisely remove the integrated provirus from infected cells and is
efﬁcacious on clinical HIV-1 isolates in vitro and in vivo (Karpinski
et al., 2016). Thus, targeting the recombinase of prophage may  be a
promising approach for treating both viral and bacterial infections.
7. Perspectives
There is growing need to understand phage-host interactions
and bacterial-host interactions in complex systems, such as among
gut microbiota. Phages can regulate the microbiome using differ-
ent strategies, such as killing competing bacteria to allow lysogenic
bacteria to thrive in niches with limited nutrients, by encoding
toxins or virulence factors that increase pathogenicity, by encod-
ing genes that increase antibiotic tolerance, and by functioning
as vehicles for the horizontal transfer of genes among different
species of bacteria. Clearly, the spread of antibiotic resistance
among pathogenic bacteria has become a serious global issue for
public health, and the role of phage in this process should not be
neglected. Increasing evidence has shown that prophages of com-
mensal and environmental bacteria are also reservoirs of antibiotic
resistance and tolerance, and their roles in the dissemination of
resistance and tolerance to pathogenic bacteria through horizontal
gene transfer should be recognized. Prophages can also carry new
families of virulence, resistance and tolerance genes. Prophages
or prophage-like elements can be identiﬁed and annotated in the
sequenced bacterial genomes through web servers such as PHAST
(Zhou et al., 2011), Prophage Finder (Bose and Barber, 2006), Island-
Viewer (Dhillon et al., 2015), and MobilomerFINDER (Ou et al.,
2007). In addition, the virome sequences that are present in publicly
available databases (e.g., MG-RAST (Keegan et al., 2016)) can also be
mined for the presence of virulence, resistance and tolerance genes
insides phages and prophages.
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The human gut also contains large amounts of free viral
articles, most of them bacteriophages probably released after
pontaneous induction of prophages of lysogenic bacteria in the
ut (Breitbart et al., 2003). A recent study by Gordon’s group
hows that temperate phages are prominent in fecal microbiota,
nd an in vivo mice study demonstrated the prophage induction in
 fecal community occurs upon exiting the host (Penadés et al.,
015). Moreover, host-associated bacteria often encounter vari-
us host-related stresses such as nutritional deprivation, oxidants,
emperature upshifts, and low pH which can also trigger prophage
xcision. Therefore, the human microbiome and environmental
icrobiome projects that have been initiated throughout the world
Dubilier et al., 2015), should strive to identify prophages and func-
ional genes embedded in the prophages, given the prominent role
f phage in virulence, antibiotic resistance, and antibiotic tolerance.
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